纯度 | >90%SDS-PAGE. |
种属 | Human |
靶点 | TSGA14 |
Uniprot No | Q9BYV8 |
内毒素 | < 0.01EU/μg |
表达宿主 | E.coli |
表达区间 | 1-301 aa |
活性数据 | MSLRRHIGNPEYLMKRIPQNPRYQHIKSRLDTGNSMTKYTEKLEEIKKNYRYKKDELFKRLKVTTFAQLIIQVASLSDQTLEVTAEEIQRLEDNDSAASDPDAETTARTNGKGNPGEQSPSPEQFINNAGAGDSSRSTLQSVISGVGELDLDKGPVKKAEPHTKDKPYPDCPFLLLDVRDRDSYQQCHIVGAYSYPIATLSRTMNPYSNDILEYKNAHGKIIILYDDDERLASQAATTMCERGFENLFMLSGGRLNQANSSGRESKVPGARSAQNLPGGGPASHSNPRSLSSGHLQGKPWK |
分子量 | 59.9 kDa |
蛋白标签 | GST-tag at N-terminal |
缓冲液 | PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300. |
稳定性 & 储存条件 | Lyophilized protein should be stored at ≤ -20°C, stable for one year after receipt. Reconstituted protein solution can be stored at 2-8°C for 2-7 days. Aliquots of reconstituted samples are stable at ≤ -20°C for 3 months. |
复溶 | Always centrifuge tubes before opening.Do not mix by vortex or pipetting. It is not recommended to reconstitute to a concentration less than 100μg/ml. Dissolve the lyophilized protein in distilled water. Please aliquot the reconstituted solution to minimize freeze-thaw cycles. |
以下是关于重组人TSGA14蛋白的示例参考文献(注:文献为虚构示例,实际文献需通过学术数据库查询):
1. **《重组人TSGA14蛋白的纯化及其在细胞迁移中的作用》**
*作者:Li X, Zhang Y, et al.*
**摘要**:本研究通过原核系统表达并纯化了重组人TSGA14蛋白,发现其能够通过调节RhoA/ROCK信号通路抑制乳腺癌细胞的迁移和侵袭,提示其在肿瘤治疗中的潜在价值。
2. **《TSGA14的结构解析及其与微管结合的分子机制》**
*作者:Wang Q, Chen M, et al.*
**摘要**:利用X射线晶体学解析了TSGA14蛋白的C端结构域,证实其通过特异性结合微管蛋白参与精子形成过程中的细胞骨架重塑,为男性不育机制提供新见解。
3. **《TSGA14在胶质母细胞瘤中的抑癌功能研究》**
*作者:Singh R, Kumar P, et al.*
**摘要**:通过体外实验证明,重组TSGA14蛋白可下调HIF-1α表达,抑制胶质母细胞瘤细胞的血管生成和增殖,表明其在癌症靶向治疗中的应用潜力。
4. **《基于重组TSGA14蛋白的多克隆抗体制备及组织定位分析》**
*作者:Garcia S, Lee H, et al.*
**摘要**:以重组TSGA14蛋白为抗原制备多克隆抗体,免疫组化显示其在睾丸、脑及多种癌细胞中高表达,验证了该蛋白的组织特异性与疾病相关性。
建议通过PubMed或Web of Science检索真实文献,关键词:**"TSGA14 protein"、"recombinant TSGA14"、"TSGA14 function"**。
**Background of TSGA14 (Testis-Specific Gene Antigen 14) Protein**
TSGA14. a protein encoded by the *TSGA14* gene, is predominantly expressed in the testis and plays a critical role in spermatogenesis. It is characterized by a conserved PHD (Plant Homeodomain) zinc finger motif, which mediates protein-protein interactions and chromatin remodeling, and a coiled-coil domain involved in oligomerization. Studies suggest TSGA14 participates in chromosomal condensation, acrosome formation, and cell division during sperm development. Notably, its expression extends beyond the male reproductive system, with aberrant levels observed in various cancers, including breast, prostate, and gliomas, indicating potential dual roles in both reproduction and oncogenesis.
In cancer biology, TSGA14 is proposed to act as a tumor suppressor by inhibiting hypoxia-inducible factor (HIF)-mediated pathways, thereby reducing angiogenesis and tumor growth. However, conflicting reports highlight context-dependent roles, as its overexpression in some malignancies correlates with aggressive phenotypes. Additionally, TSGA14 interacts with proteins involved in DNA repair (e.g., RAD51) and apoptotic regulation, suggesting broader functional versatility.
Emerging evidence links TSGA14 mutations or dysregulation to infertility and cancer progression, positioning it as a biomarker or therapeutic target. Ongoing research aims to elucidate its molecular mechanisms and tissue-specific functions, bridging reproductive biology and cancer research. Animal models with *TSGA14* knockout exhibit impaired sperm maturation, reinforcing its indispensability in fertility. Further exploration of its dual roles may unlock clinical applications in both andrology and oncology.
×